Position in AQST
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,392,088
+$562,134 QoQ
Shares Held
335,443
+161.1% QoQ
Ownership
0.267%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $21,852,087 across 7 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
105,781 | $8,433,919 | |
| 2 | HROW |
Harrow, Inc.
|
116,908 | $4,965,082 | |
| 3 | ETON |
Eton Pharmaceuticals, Inc.
|
73,101 | $2,646,256 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
26,976 | $2,233,073 | |
| 5 | DERM |
Journey Medical Corp
|
295,663 | $2,093,294 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
7,486 | $1,261,690 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
1,972 | $218,773 |
All Filings in AQST
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,392,088 | 335,443 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $829,954 | 128,476 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $777,412 | 139,072 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $547,384 | 165,373 | Shares | Defined | 2025-08-13 | |
| 2024-12-31 | $125,650 | 35,295 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $225,743 | 45,330 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $631,051 | 242,712 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $290,054 | 68,088 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||